Literature DB >> 30779594

Borderline Brenner Tumor: A Review of the Literature.

Ruifang Zheng1, Debra S Heller1.   

Abstract

Brenner tumors arise from ovarian epithelium, accounting for approximately 5% of benign ovarian epithelial tumors. The World Health Organization classification groups them into benign, borderline, and malignant on the basis of proliferation and invasiveness, and borderline Brenner tumor is defined as "displaying epithelial proliferation beyond that seen in benign Brenner's tumor, but lacking stromal invasion." Borderline Brenner tumors are rare. Fewer than 60 cases have been reported. The more recent articles mostly focus on pathogenesis. We reviewed the literature on borderline Brenner tumor and have summarized the clinical and pathologic findings, as well as the treatment, differential diagnoses, and recent advances in histogenesis and molecular pathogenesis.

Entities:  

Year:  2019        PMID: 30779594     DOI: 10.5858/arpa.2018-0285-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Brenner tumors.

Authors:  Filipa de Sousa Costeira; Ana Félix; Teresa Margarida Cunha
Journal:  Br J Radiol       Date:  2021-12-20       Impact factor: 3.039

2.  Brenner tumors of the ovary: clinical features and outcomes in a single-center cohort

Authors:  Dilek Yüksel; Ciğdem Kılıç; Caner Çakır; Günsu Kimyon Cömert; Taner Turan; Eylem Ünlübilgin; Nurettin Boran; Fulya Kayıkçıoğlu; Sevgi Koç
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-01-10

3.  Coexistence of malignant ovarian Brenner tumor and borderline mucinous cystadenoma, combined with primary uterine corpus endometrioid carcinoma: A case report and literature review.

Authors:  Cancan Zou; Qiong Li; Jingbo Zhao; Yanlin Chen
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

4.  A case of a vaginal Brenner tumor without a gland mimicking a borderline tumor: unusual morphology and diagnostic pitfalls.

Authors:  Qin Zhang; Can Tian; Kun Wang; Qi Xin; Yan Shen; Chuan-Shan Zhang; Zhe Ma
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.